Impact of Metabolic Syndrome and Its Individual Components on the Presence and Severity of Angiographic Coronary Artery Disease

키워드

참고문헌 (33)

1. Reaven GM, "Banting lecture 1988. Role of insulin resistance in human disease", Diabetes, 37, pp.1595~1607 (1988)
2. James PT, "The obesity epidemic, metabolic syndrome and future prevention strategies", Eur J Cardiovasc Prev Rehabil, 11, pp.3~8 (2004)
3. Jørgensen ME, "The metabolic syndrome--is one global definition possible?", Diabet Med, 21, pp.1064~1065 (2004)
4. Ford ES, "Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence", Diabetes Care, 28, pp.1769~1778 (2005)
5. Galassi A, "Metabolic syndrome and risk of cardiovascular disease: a meta-analysis", Am J Med, 119, pp.812~819 (2006)
6. Gami AS, "Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies", J Am Coll Cardiol, 49, pp.403~414 (2007)
7. Solymoss BC, "Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease", Coron Artery Dis, 14, pp.207~212 (2003)
8. Iribarren C, "The metabolic syndrome is no better than its components", Minerva Cardioangiol, 55, pp.487~489 (2007)
9. Wang J, "The metabolic syndrome predicts cardiovascular mortality:a 13-year follow-up study in elderly non-diabetic Finns", Eur Heart J, 28, pp.857~864 (2007)
10. Solymoss BC, "Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity", Am J Cardiol, 93, pp.159~164 (2004)
11. Azevedo A, "Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population", BMC Cardiovasc Disord, 7, pp.17~ (2007)
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106, pp.3143~3421 (2002)
14. Grundy SM, "Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome", Am J Cardiol, 81, pp.18B~25B (1998)
15. Genuth S, "Follow-up report on the diagnosis of diabetes mellitus", Diabetes Care, 26, pp.3160~3167 (2003)
16. Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
17. Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
18. Gensini GG, "A more meaningful scoring system for determining the severity of coronary heart disease", Am J Cardiol, 51, pp.606~ (1983)
19. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
20. Kahn R, "The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes", Diabetes Care, 28, pp.2289~2304 (2005)
21. Clemenz M, "The metabolic syndrome:cluster with a self-fulfilling loop?", J Hypertens, 24, pp.257~258 (2006)
22. Greenland P, "Critical questions about the metabolic syndrome", Circulation, 112, pp.3675~3676 (2005)
23. Stern MP, "Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and", or cardiovascular disease?, 2004, pp.27, 2676~2681
24. McNeill AM, "The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study", Diabetes Care, 28, pp.385~390 (2005)
25. Golden SH, "Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study", Diabetes, 51, pp.3069~3076 (2002)
26. Hassinen M, "Metabolic syndrome and the progression of carotid intima-media thickness in elderly women", Arch Intern Med, 166, pp.444~449 (2006)
27. Wannamethee SG, "Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus", Arch Intern Med, 165, pp.2644~2650 (2005)
28. Sattar N, "Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies", Lancet, 371, pp.1927~1935 (2008)
29. Marquis K, "The metabolic syndrome in patients with chronic obstructive pulmonary disease", J Cardiopulm Rehabil, 25, pp.226~232 (2005)
30. Bonora E, "The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study", Diabet Med, 21, pp.52~58 (2004)
31. Meigs JB, "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease", J Clin Endocrinol Metab, 91, pp.2906~2912 (2006)
32. McLaughlin T, "Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity", Arch Intern Med, 167, pp.642~648 (2007)
33. Park HS, "Prevalence of obesity and metabolic syndrome in Korean adults", Obes Rev, 9, pp.104~107 (2008)

관련 논문AI추천